Tag Archives: NDA

Biopharma, Specialty Drug, Specialty HUBs

EVERSANA Selected by Tonix Pharmaceuticals to Help Launch Tonmya

Posted on by John Santilli

Tonix selected EVERSANA® to support the launch strategy and commercial planning of Tonmya for the management of fibromyalgia

Continue reading →
Specialty Drug, Specialty Pharmacy

GBT’s Oxbryta® Accepted by FDA for Priority Review for Pediatric Sickle Cell Disease

Posted on by John Santilli

The FDA has accepted for Priority Review the supplemental New Drug Application (sNDA) for voxelotor (Oxbryta®) for the treatment of sickle cell disease in patients aged 4 to 11 years

Continue reading →
Specialty Drug, Specialty HUBs

SCYNEXIS Partnering with Amplity Health to Launch BrexafemmeTM

Posted on by John Santilli
29
Mar

SCYNEXIS announced that it has partnered with Amplity Health, a leading global contract commercialization organization, to support the anticipated U.S. commercialization of Brexafemme

Continue reading →